Gurpharma Global

The 150mg Zyceva Erlotinib Tablet is a prescription anti-cancer medication manufactured by Zydus Lifesciences. Its active ingredient, erlotinib, is a targeted therapy used to treat certain types of lung and pancreatic cancers. 

The 150mg Erlocip Erlotinib Tablet is a prescription anti-cancer medication manufactured by Cipla Ltd. in India. It contains the active ingredient erlotinib, a targeted therapy used to treat certain types of advanced lung and pancreatic cancers. 

Erlonat 150 Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer.

Erlonat 150 Tablet should be taken on an empty stomach or should be taken one hour before or 2 hour after meal.  You should continue to take it as long as your doctor advises it. The duration of treatment varies according to your needs and response to treatment. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Zyceva (erlotinib) is an anti-cancer medication used primarily to treat advanced non-small cell lung cancer (NSCLC) with specific EGFR mutations and pancreatic cancer (in combination with gemcitabine). It works as a tyrosine kinase inhibitor to slow or stop cancer cell growth.